Stocktoria
HAEMONETICS CORP HAE
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1979-10-17
HAEMONETICS CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Operating margin | 11.7% | 16.3% | 12.6% | 13.4% | 8.1% |
| Net margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% |
| FCF margin | 19.5% | 10.5% | 11.0% | 7.0% | 7.6% |
| Return on assets | 4.1% | 6.8% | 5.4% | 6.0% | 2.3% |
| Return on equity | 12.2% | 20.4% | 12.2% | 14.1% | 5.8% |
| Debt / equity | 1.56× | 1.49× | 0.83× | 0.92× | 0.75× |
| Current ratio | 2.95 | 1.62 | 2.56 | 3.06 | 1.71 |
| Revenue growth | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% |
Source: SEC EDGAR filings · CIK 0000313143 · as of 2026-03-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.